Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Delcath Systems Inc (DCTH)  
$4.77 0.32 (6.29%) as of 4:30 Thu 3/28


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 15,280,000
Market Cap: 72.89(M)
Last Volume: 1,505,916 Avg Vol: 1,501,622
52 Week Range: $2.25 - $7.96
Level I Sector: Industrials
Level II Sector: Diversified Services
Level III Sector: Research Services

Member Indexes:

    NASDAQ COMPOSITE

Rankings:

     
Insider 3 Months    : 8.6
Insider 6 Months    : 15.5
Insider 3/6 Months : 24.3
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Delcath Systems is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. Co.'s primary product candidate, the HEPZATO™ KIT (melphalan hydrochloride for injection/hepatic delivery system) (HEPZATO), is a drug/device combination product. HEPZATO is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. In Europe, Co.'s commercial product is a stand-alone medical device having the same device components as the HEZPATO but without the melphalan hydrochloride and is approved for sale under the trade name CHEMOSAT® Hepatic Delivery System for Melphalan.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 53,764 372,269 402,465 589,934
Total Buy Value $200,002 $1,031,169 $1,176,896 $1,938,525
Total People Bought 2 7 8 9
Total Buy Transactions 2 9 11 33
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 118
  Page 1 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Salamon Steven A J Director   –       •      –    2024-03-19 4 B $3.72 $100,001 D/D 26,882 1,121,025 2.39 19%     
   Aharon Gil Director   –       •      –    2024-03-19 4 B $3.72 $100,001 D/D 26,882 1,069,710 2.39 19%     
   Hoffman David L. GENL COUNSEL, CCO & SECY   •       –      –    2024-03-19 4 A $3.72 $74,999 D/D 20,161 74,330     -
   Pennell Sandra SVP OF FINANCE, PFO AND PAO   •       –      –    2024-03-19 4 A $3.72 $99,997 D/D 26,881 61,052     -
   Muir Kevin GM INTERVENTIONAL ONCOLOGY   •       –      –    2024-03-19 4 A $3.72 $50,001 D/D 13,441 18,582     -
   Vukovic Vojo CHIEF MEDICAL OFFICER   •       –      –    2024-03-19 4 A $3.72 $100,001 D/D 26,882 126,882     -
   Michel Gerard J CHIEF EXECUTIVE OFFICER   •       •      –    2024-03-19 4 A $3.72 $150,002 D/D 40,323 302,668     -
   Vukovic Vojo Chief Medical Officer   •       –      –    2023-12-12 4 B $3.00 $120,000 D/D 40,000 100,000 2.74 63%     
   Michel Gerard J Chief Executive Officer   •       •      –    2023-12-08 4 B $2.94 $99,960 D/D 34,000 262,345 2.81 71%     
   Aharon Gil Director   –       •      –    2023-11-17 4 B $2.40 $240,410 I/I 100,000 1,038,828 2.1 108%     
   Pennell Sandra SVP of Finance, PFO and PAO   •       –      –    2023-11-17 4 B $2.43 $72,900 D/D 30,000 30,000 2.74 108%     
   Vukovic Vojo Chief Medical Officer   •       –      –    2023-11-16 4 B $2.48 $148,800 D/D 60,000 60,000 2.74 106%     
   Hoffman David L. See Remarks   •       –      –    2023-11-16 4 B $2.48 $99,200 D/D 40,000 40,000 2.74 106%     
   Purpura John Chief Operating Officer   •       –      –    2023-10-13 4 B $3.44 $49,897 D/D 14,505 41,526 2.74 25%     
   Sylvester John Richard Director   –       •      –    2023-08-21 4 B $4.80 $50,640 D/D 10,550 10,550 2.39 -18%     
   Michel Gerard J Chief Executive Officer   •       •      –    2023-08-18 4 OE $4.50 $139,995 D/D 31,110 228,345     -
   Michel Gerard J Chief Executive Officer   •       •      –    2023-03-29 4 B $4.84 $95,087 D/D 19,646 197,235 2.81 -27%     
   Salamon Steven A J Director   –       •      –    2022-12-14 4 B $3.62 $55,045 D/D 15,215 455,315 2.39 54%     
   Rosalind Advisors, Inc. Director   –       •      –    2022-12-14 4 B $3.62 $55,045 I/I 15,215 459,315 2.1 54%     
   Michel Gerard J Chief Executive Officer   •       •      –    2022-12-13 4 B $2.90 $150,003 D/D 51,725 177,589 2.81 54%     
   Michel Gerard J Chief Executive Officer   •       •      –    2022-07-20 4 B $3.98 $250,000 D/D 62,814 125,864 2.81 -29%     
   Purpura John Chief Operating Officer   •       –      –    2022-05-16 4 B $4.61 $15,213 D/D 3,300 27,021 2.74 -30%     
   Salamon Steven A J Director   –       •      –    2022-05-13 4 B $5.03 $25,135 I/I 5,000 440,100 2.1 -32%     
   Salamon Steven A J Director   –       •      –    2022-05-12 4 B $4.90 $29,424 I/I 6,000 29,424 2.1 -27%     
   Rosalind Advisors, Inc. Director   –       •      –    2022-04-19 4 B $6.25 $10,000 I/I 1,600 433,100 2.1 -34%     

  118 Records found
  1  2  3  4  5   
  Page 1 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed